192 related articles for article (PubMed ID: 26739488)
1. Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus.
Urbano F; Filippello A; Di Pino A; Barbagallo D; Di Mauro S; Pappalardo A; Rabuazzo AM; Purrello M; Purrello F; Piro S
Am J Physiol Cell Physiol; 2016 Apr; 310(7):C558-67. PubMed ID: 26739488
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling protein 2 regulates glucagon-like peptide-1 secretion in L-cells.
Chen Y; Li ZY; Yang Y; Zhang HJ
World J Gastroenterol; 2012 Jul; 18(26):3451-7. PubMed ID: 22807616
[TBL] [Abstract][Full Text] [Related]
3. The incretin system and its role in type 2 diabetes mellitus.
Holst JJ; Vilsbøll T; Deacon CF
Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
[TBL] [Abstract][Full Text] [Related]
4. Increased GLP-1 response after gavage-administration of glucose in UCP2-deficient mice.
Zhang H; Li J; Li Z; Luo Y
Horm Metab Res; 2012 Feb; 44(2):86-90. PubMed ID: 22198816
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling protein 2 negatively regulates glucose-induced glucagon-like peptide 1 secretion.
Zhang H; Li J; Liang X; Luo Y; Zen K; Zhang CY
J Mol Endocrinol; 2012 Apr; 48(2):151-8. PubMed ID: 22257551
[TBL] [Abstract][Full Text] [Related]
6. Synaptotagmin-7 as a positive regulator of glucose-induced glucagon-like peptide-1 secretion in mice.
Gustavsson N; Wang Y; Kang Y; Seah T; Chua S; Radda GK; Han W
Diabetologia; 2011 Jul; 54(7):1824-30. PubMed ID: 21424898
[TBL] [Abstract][Full Text] [Related]
7. Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.
Holst JJ; McGill MA
Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 27933595
[TBL] [Abstract][Full Text] [Related]
8. Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrants.
Holst JJ; McGill MA
Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 21958333
[TBL] [Abstract][Full Text] [Related]
9. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.
Vaag AA; Holst JJ; Vølund A; Beck-Nielsen HB
Eur J Endocrinol; 1996 Oct; 135(4):425-32. PubMed ID: 8921824
[TBL] [Abstract][Full Text] [Related]
10. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
[TBL] [Abstract][Full Text] [Related]
11. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
12. Costus pictus D. Don leaf extract stimulates GLP-1 secretion from GLUTag L-cells and has cytoprotective effects in BRIN-BD11 β-cells.
Patibandla C; Khan ZI; MacGregor L; Campbell MJ; Patterson S
J Ethnopharmacol; 2020 Oct; 260():112970. PubMed ID: 32422353
[TBL] [Abstract][Full Text] [Related]
13. Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity.
Vasu S; Moffett RC; McClenaghan NH; Flatt PR
Exp Cell Res; 2015 Aug; 336(1):100-8. PubMed ID: 26027945
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X Receptor (FXR) Interacts with Camp Response Element Binding Protein (CREB) to Modulate Glucagon-Like Peptide-1 (7-36) Amide (GLP-1) Secretion by Intestinal L Cell.
Li P; Zhu L; Yang X; Li W; Sun X; Yi B; Zhu S
Cell Physiol Biochem; 2018; 47(4):1442-1452. PubMed ID: 29940597
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
Pathak V; Vasu S; Flatt PR; Irwin N
Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects.
Kappe C; Fransson L; Wolbert P; Ortsäter H
Clin Sci (Lond); 2015 Sep; 129(5):405-14. PubMed ID: 25853863
[TBL] [Abstract][Full Text] [Related]
17. RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice.
Pais R; Zietek T; Hauner H; Daniel H; Skurk T
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G330-7. PubMed ID: 24875103
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell.
Li P; Zhu L; Yang X; Li W; Sun X; Yi B; Zhu S
J Cell Physiol; 2019 Aug; 234(8):12839-12846. PubMed ID: 30536761
[TBL] [Abstract][Full Text] [Related]
19. Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.
Freeman JS
Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S12-9. PubMed ID: 19952298
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glucagon secretion by incretins.
Holst JJ; Christensen M; Lund A; de Heer J; Svendsen B; Kielgast U; Knop FK
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():89-94. PubMed ID: 21824261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
